These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4623679)

  • 21. A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.
    Thibault A
    Curr Med Res Opin; 1974; 2(8):482-7. PubMed ID: 4217240
    [No Abstract]   [Full Text] [Related]  

  • 22. [Electroencephalographic findings in cerebral vascular diseases in aged patients and their changes under the influence of sympatholytic (Hydergine) therapy].
    Kauchtschischwili GM; Pontiggia M; Zerbi F
    Riv Neurol; 1967; 37(3):231-50. PubMed ID: 4965103
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hydergine in the treatment of chronic psychoses].
    Bohard F; Guennoc A; Klein H; Le Borgne Y; Masanes P
    Ann Med Psychol (Paris); 1967 Mar; 125(3):438-46. PubMed ID: 4964710
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of ergot alkaloids (hydergine) on cerebral hemodynamics and oxygen consumption in monkeys.
    Szewczykowski J; Meyer JS; Kondo A; Nomura F; Teraura T
    J Neurol Sci; 1970 Jan; 10(1):25-31. PubMed ID: 4983718
    [No Abstract]   [Full Text] [Related]  

  • 25. [Electroencephalographic findings in the course of cerebrovascular diseases in aged subjects and their changes under the influence of sympathicolytic therapy (hydergine)].
    Kauchtschischwili GM; Pontiggia M; Zerbi F
    G Gerontol; 1966 Dec; 14(12):1221-5. PubMed ID: 4966653
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of the administration of the drug association: hydergine-thioridazine (HM 51), in the treatment of coronary angina].
    Martelli A; Melilla GN
    G Clin Med; 1968 Mar; 49(3):310-43. PubMed ID: 4985903
    [No Abstract]   [Full Text] [Related]  

  • 27. [Raubasine in combination with ergot alkaloid derivatives in the therapy of closed injuries of the brain].
    Stoppani L
    Arch Sci Med (Torino); 1965 Nov; 120(5):431-9. PubMed ID: 4956319
    [No Abstract]   [Full Text] [Related]  

  • 28. [CLINICAL STUDY ON AN ERGOT DERIVATIVE: HYDERGINE].
    REBECCHI M; GOTTI A; BENEDETTI L
    Gazz Int Med Chir; 1964 Jan; 68():207-11. PubMed ID: 14154380
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic findings in 23 geriatric cases treated with hydergine (clinical note)].
    Tessler D
    Hospital (Rio J); 1970 Jul; 78(1):267-70. PubMed ID: 4991827
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of ergot alkaloids (Hydergine) on cerebral haemodynamics in man.
    Olesen J; Skinhej E
    Acta Pharmacol Toxicol (Copenh); 1972; 31(1):75-85. PubMed ID: 4623450
    [No Abstract]   [Full Text] [Related]  

  • 31. [USE OF THE ERGOT ALKALOID PREPARATION, HYDERGINE, IN SURGERY].
    WATANUKI T; ISHIZUKA T; MOCHIZUKI N
    Rinsho Geka; 1964 May; 19():694-9. PubMed ID: 14148895
    [No Abstract]   [Full Text] [Related]  

  • 32. [ELECTROCARDIOGRAMS IN NEUROVEGETATIVE DYSTONIA IN AGED SUBJECTS AND DIFFERENTIAL DIAGNOSTIC VALUE OF THE HYDERGINE TEST].
    NECCHIDELLASILVA A
    G Gerontol; 1964 Feb; 12():251-5. PubMed ID: 14163042
    [No Abstract]   [Full Text] [Related]  

  • 33. [Determinants estimating cerebral functions after long term therapy with hydergin].
    Herzfeld U; Christian W; Ronge J; Wittgen M
    Arztl Forsch; 1972 Jun; 26(6):215-28. PubMed ID: 4626216
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B; Rimondini S; Martelli A
    Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract]   [Full Text] [Related]  

  • 35. Hydergine for dementia.
    Olin J; Schneider L; Novit A; Luczak S
    Cochrane Database Syst Rev; 2000; 2000(2):CD000359. PubMed ID: 10796534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blood pressure in the treatment of hypertension with hydergine].
    PLAZA DE LOS REYES M; JUNEMANN C; CAMPOS R; WESCHLER A
    Rev Med Chil; 1952 Nov; 80(11):681-5. PubMed ID: 13047946
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of treatment on symptomatology and correlated electroencephalographic (EEG) changes in the aged.
    Arrigo A; Braun P; Kauchtschischwili GM; Moglia A; Tartara A
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):417-26. PubMed ID: 4198303
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of hydergine in the psychiatric setting. Clinical study comprising 107 patients of the Hôpital Psychiatrique de Pierrefeu (Var)].
    Boutillier H; Bodilis A; Grégoire F
    Sem Ther; 1967 May; 43(5):300-4. PubMed ID: 4970731
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hydergine test and pulmonary pressure; first results].
    MERIEL P; BOLLINELLI R; CALAZEL P; CASSAGNEAU J
    Arch Mal Coeur Vaiss; 1953 Apr; 46(4):329-40. PubMed ID: 13066173
    [No Abstract]   [Full Text] [Related]  

  • 40. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
    van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
    J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.